Search results
Jul 18, 2024 · Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics.
Jul 13, 2024 · Danaher Corporation (NYSE:DHR) reported strong Q1 results with $5.8 billion in revenue and $1.92 in adjusted diluted EPS, driven by growth in bioprocessing and subsidiary Cepheid.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process ...
Stock analysis for Danaher Corp (DHR:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Jul 16, 2024 · WASHINGTON, July 16, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report which conveys the depth and scope of Danaher's sustainability program and highlights important milestones the Company achieved during the past year.
1 day ago · Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and ...
4 days ago · Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and ...
